Login
Israel-Hamas Conflict
Memorial Day
Cannes Film Festival
South America
Harvard
Social Media
Formula 1
Artificial Intelligence
Premier League
Natural Disasters
Donald Trump
Soccer
Education
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published • loading... • Updated

Just Say No To Drugs

Summary by RealClearMarkets
Bill Smead, Smead Capital Management "Compared to most stocks, Merck is a bargain, and we are looking to take the most advantage of what we view as a major mispricing in the sector."

1 Articles

All
Left
Center
Right
1
RealClearMarketsRealClearMarkets
Lean Right

Just Say No To Drugs

Bill Smead, Smead Capital Management "Compared to most stocks, Merck is a bargain, and we are looking to take the most advantage of what we view as a major mispricing in the sector."

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Right
100% Right
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

RealClearMarkets broke the news in on Friday, May 23, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Stock Markets

Stock Markets

Merck

Merck

News
For You
SearchBlindspotLocal